Nevertheless, the observed decrease in MAS1 levels in breast cancer was associated with tumor growth, lymph node metastasis, and increased tumor grade as well as increased MIB-1 proliferation index and epidermal growth factor receptor (EGFR) and tyrosine-protein kinase erbB-2 receptor (HER2) gene expression4. This evidence concerns the gene ERBB2 and breast carcinoma.